Citation

Beirness DJ, Notarandrea R, Jesseman R, Perron M. Clin. Pharmacol. Ther. 2008; 83(4): 523-525.

Affiliation

Canadian Centre on Substance Abuse, Ottawa, Ontario, Canada. DBeirness@ccsa.ca

Comment On:

Clin Pharmacol Ther 2008;83(4):513-4.

Copyright

(Copyright © 2008, American Society for Clinical Pharmacology and Therapeutics, Publisher Nature Publishing Group)

DOI

10.1038/sj.clpt.6100509

PMID

18349874

Abstract

The article in this issue by Alan Leshner tackles one of the most contentious issues in drug use policy today and argues that we should dispense with "harm reduction" altogether--not the programs, policies, and interventions to which this term refers but the term itself. He makes the case that the initial clarity and simplicity of the phrase "harm reduction" have evolved into an emotion-laden designation that is interfering with the implementation and evaluation of public health programs.

Language: en